TY  - JOUR

TI  - Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Ready to Target Atherosclerotic Cardiovascular Disease beyond Statins
JO  - The Journal of Hypertension
PY  - 2026
ER  -